510(k) K202174
K202174 is an FDA 510(k) premarket notification submitted by Blackrock Microsystems for the device "Digital NeuroPort Biopotential Signal Processing System". The FDA issued a decision of Substantially Equivalent on Feb 10, 2021. The device falls under product code GWL (Amplifier, Physiological Signal), a Class II device regulated under 21 CFR 882.1835. Blackrock Microsystems has 2 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Feb 10, 2021
- Date Received
- Aug 4, 2020
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Amplifier, Physiological Signal
- Device Class
- Class II
- Regulation Number
- 882.1835
- Review Panel
- NE
- Submission Type
- 510(k)
Need the full FDA record for Blackrock Microsystems? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.